Veeva Systems Reports Strong FY26 Results, $180M Share Repurchase, and Ostro Acquisition Details
Summary
Veeva Systems reported strong fiscal year 2026 financial results, including 16% revenue growth and 27% net income growth, alongside the execution of a $180 million share repurchase and the formal disclosure of the strategic Ostro acquisition.
Key Events
-
Strong Fiscal Year 2026 Financial Performance
Veeva Systems reported total revenues of $3.195 billion for fiscal year 2026, a 16% increase year-over-year. Net income grew by 27.3% to $908.9 million, and diluted EPS increased by 25.9% to $5.44.
-
$180 Million Share Repurchase Completed
The company repurchased 801,735 shares of common stock for approximately $180 million during the fiscal year ended January 31, 2026, under the $2 billion program authorized in January 2026. Approximately $1.82 billion remains available for future repurchases.
-
Strategic Acquisition of Ostro Confirmed
Veeva Systems formally disclosed the acquisition of Rise Healthcare Tech, Inc. ('Ostro') on March 10, 2026, for approximately $100 million in cash and long-term equity retention grants. Ostro provides an AI-driven chat engagement platform for life sciences.
-
Resolution of IQVIA Litigation
On August 13, 2025, Veeva and IQVIA entered into a settlement agreement, resolving all ongoing litigations without either party paying damages to the other. Veeva paid approximately $31 million to its law firms for contingency fees.
Analysis
Veeva Systems delivered robust financial performance for fiscal year 2026, with significant growth in revenue, net income, and diluted EPS. The company also executed a substantial portion of its share repurchase program, returning capital to shareholders. The formal disclosure of the Ostro acquisition, a strategic move into AI-driven engagement platforms, confirms prior news with financial specifics. The resolution of long-standing litigation with IQVIA removes a key uncertainty, while the ongoing transition of Veeva CRM from the Salesforce platform to its own Vault CRM continues as a major strategic initiative.
At the time of this filing, VEEV was trading at $184.07 on NYSE in the Technology sector, with a market capitalization of approximately $30.3B. The 52-week trading range was $168.14 to $310.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.